NCT04431167

Brief Summary

This research program aims to investigate the clinical, physiological, metabolic and molecular effects of lifestyle change in patients with systemic lupus erythematosus with high cardiovascular risk. This 6-month parallel-group randomized controlled trial aims to investigate the feasibility and efficacy of a newly developed lifestyle change intervention - through recommendations for structured and unstructured physical activity and healthy eating - on increasing physical activity level and improving eating habits. Potential effects of the intervention on cardiovascular and cardiometabolic risk factors, health-related quality of life, symptoms of anxiety and depression, sleep quality and immune function will be investigated. Gold-standard techniques and a variety of analyses will be performed to access the potential mechanisms involved in response to this intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2023

Completed
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

February 18, 2020

Last Update Submit

December 5, 2024

Conditions

Keywords

Life styleBehavioral interventionCardiovascular riskLife quality

Outcome Measures

Primary Outcomes (1)

  • Risk cardiovascular score

    assessed by measures of five standard variables (HDL cholesterol, triglycerides, fasting blood glucose, waist circumference and blood pressure - average of systolic and diastolic blood pressures). Z-score = \[(50 - HDL cholesterol)/sd + (triglycerides - 150)/ sd\] + \[(fasting blood glucose - 100)/ sd\] + \[(waist circumference - 88)/ sd\] + \[(blood pressure - 115)/ sd\]. Higher score values represent higher risk. \*sd: standard deviation. Higher Z-score represent higher risk.

    6 months

Secondary Outcomes (27)

  • Body mass index (BMI)

    6 months

  • Waist circumference (cm)

    6 months

  • Total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides

    6 months

  • Insulin sensitivity

    6 months

  • Systolic and Diastolic blood pressure

    6 months

  • +22 more secondary outcomes

Study Arms (2)

Living well with Lupus Group

EXPERIMENTAL

A newly developed intervention focused on promoting lifestyle change through recommendations for structured and unstructured physical activity and healthy eating.

Behavioral: Living well with Lupus

Usual Care Group

NO INTERVENTION

This group will receive all regular medical care and advice healthy

Interventions

The lifestyle change intervention will involve two constructs: increasing the level of physical activity and improving eating habits, each with its own specific domains and goals. It will be based on a structured program of physical exercises and selection of individualized goals in the domains of transportation, leisure and work to reduce sedentary behavior with the aim of increasing the level of physical activity, as well as establishing changes in dietary aspects, involving consumption domains, structure, behavior and eating attitude using nutritional counseling techniques.

Living well with Lupus Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants will be eligible
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women between 18 and 65 years old diagnosed with systemic lupus erythematosus
  • one or more high cardiovascular risk factors
  • SLEDAI score ≤ 4
  • Treatment with prednisone at a dosage \<10 mg/d and treatment with hydroxychloroquine in a stable dose

You may not qualify if:

  • another rheumatic diseases (except for secondary Sjogren's syndrome)
  • participation in structured exercise training programs and/or prescriptive diets
  • illiterate or with diagnosed cognitive disorders or musculoskeletal impairments that potentially compromise understanding and participation in the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, 05403-010, Brazil

Location

Related Publications (3)

  • Caruso Mazzolani B, Infante Smaira F, Mendes Sieczkowska S, Romero M, C Santo Andre H, G Pasoto S, de Sa Pinto AL, Rodrigues Lima F, Braga Benatti F, Roschel H, Weber MB, Gualano B. Acceptability and impact of a lifestyle intervention for systemic lupus erythematosus: Qualitative analysis of living well with lupus study. Lupus. 2025 Apr;34(5):474-483. doi: 10.1177/09612033251326986. Epub 2025 Mar 13.

  • Sieczkowska SM, Mazzolani BC, Smaira FI, Romero M, Pasoto SG, de Sa Pinto AL, Lima FR, De Oliveira VR, Ueda S, Benatti FB, Roschel H, Gualano B. Effects of a lifestyle intervention on cardiovascular risk factors in systemic lupus erythematosus patients: The study "Living well with lupus". Clin Rheumatol. 2024 Mar;43(3):1003-1013. doi: 10.1007/s10067-024-06870-2. Epub 2024 Jan 27.

  • Sieczkowska SM, Smaira FI, Mazzolani BC, Romero M, Pasoto SG, de Sa Pinto AL, Lima FR, De Oliveira VR, Ueda S, Benatti FB, Roschel H, Gualano B. A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study "Living Well with Lupus". Rheumatol Int. 2023 Oct;43(10):1799-1810. doi: 10.1007/s00296-023-05370-x. Epub 2023 Jun 24.

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researcher responsible for performing the blood flow measurement will be blinded to the allocation of groups
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental group and no intervention group (usual care group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 18, 2020

First Posted

June 16, 2020

Study Start

December 1, 2020

Primary Completion

February 28, 2023

Study Completion

August 28, 2023

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

we can share the individual data of the participants if the request is reasonable

Locations